Kjellin Midori, Wesslén Terése, Löfblad Erik, Lennerstrand Johan, and Lannergård Anders. “The Effect of the First-Generation HCV-Protease Inhibitors Boceprevir and Telaprevir and the Relation to Baseline NS3 Resistance Mutations in Genotype 1: Experience from a Small Swedish Cohort”. Upsala Journal of Medical Sciences 123, no. 1 (March 14, 2018): 50–56. Accessed July 22, 2024. https://ujms.net/index.php/ujms/article/view/5824.